- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 444M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 457M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $486M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $139M |
| Capex | Q1 2026 · Mar 31, 2026 | $72M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $969M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $755M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.89B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.87B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.41B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.48B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.13B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.64B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $13.48B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $12.95B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.26B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.09B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $17.89B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $17.44B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.12 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.14 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $410M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $450M |
| Net Income | Q1 2026 · Mar 31, 2026 | $512M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $611M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.29B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $802M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.09B |